Search results for "memorial delirium assessment scale"

showing 2 items of 2 documents

Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit

2017

Background: Delirium is often unrecognized in cancer patients. The aim of this study was to investigate the prevalence of delirium assessed by the Memorial Delirium Assessment Scale (MDAS) and possible associated factors on admission to an acute palliative/supportive care unit (APSCU). The secondary outcome was to assess changes in MDAS and symptom burden at time of discharge. Methods: A consecutive sample of advanced cancer patients who were admitted to an APSCU was prospectively assessed for a period of 10 months. Patient demographics, including age, gender, primary diagnosis, Karnofsky status, stage of disease, and educational level were collected. The Edmonton Symptom Assessment Scale (…

Malemedicine.medical_specialtyPalliative careDiseaseCONSECUTIVE SAMPLE03 medical and health sciences0302 clinical medicineNeoplasmsAdvanced cancerparasitic diseasesmedicinePrevalenceHumans030212 general & internal medicineKarnofsky Performance StatusStage (cooking)Intensive care medicineReferral and ConsultationAgedAged 80 and overpalliative carebusiness.industryMedicine (all)edmonton symptom assessment scaleCancerDeliriummemorial delirium assessment scaleGeneral MedicineAssessment scaleLength of StayMiddle Agedmedicine.diseaseAdvanced cancerPatient DischargeHospitalization030220 oncology & carcinogenesisEmergency medicineDeliriumNeoplasmFemaleKarnofsky Performance Statumedicine.symptombusinessHuman
researchProduct

Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium

2018

Abstract Aim The aim of this study was to investigate the relationship between delirium and symptom expression in patients with advanced cancer admitted to an acute supportive/palliative care unit (ASPCU). Methods A consecutive sample of patients with advanced cancer who were admitted to an ASPCU was prospectively assessed for a period of 10 months. The Edmonton Symptom Assessment Scale (ESAS) and the MDAS (Memorial Delirium Assessment Scale) were measured at admission (T0) and after 7 days of palliative care (T7). Results Two hundred forty-six patients had complete data regarding MDAS measurements, at either T0 and T7. Of these, 75 (30.5%) and 63 patients (25.6%) had delirium at T0 and aft…

MaleCancer Researchmedicine.medical_specialtyWeaknessPalliative careNauseaNeuropsychological TestsSeverity of Illness Indexbehavioral disciplines and activities03 medical and health sciencesCognition0302 clinical medicineAdvanced cancerNeoplasmsInternal medicinemental disordersHumansMedicineProspective Studies030212 general & internal medicineKarnofsky Performance StatusDepression (differential diagnoses)Edmonton Symptom Assessment ScaleAgedNeoplasm StagingPain MeasurementDepressionbusiness.industryPalliative CareDeliriumCancerMemorial Delirium Assessment ScaleCancer PainMiddle Agedmedicine.diseaseAdvanced cancernervous system diseasesHospitalizationTreatment OutcomeOncologySymptom Management and Supportive Care030220 oncology & carcinogenesisBehavior Rating ScaleAnxietyDeliriumFemaleSymptom Assessmentmedicine.symptombusinessThe Oncologist
researchProduct